Search results
Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration
Morningstar· 2 days agoEditas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage gene editing company, today announced a two-year extension to the collaboration with Bristol Myers Squibb (NYSE: BMY) under which the parties ...
‘ChatGPT for CRISPR’ creates new gene-editing tools
Nature· 4 days agoSome of the AI-designed gene editors could be more versatile than those found in nature.
Dad’s microbiome can affect offspring’s health — in mice
Nature· 2 days agoHear the biggest stories from the world of science | 1 May 2024
iJAZ-based approach to engineer lepidopteran pest resistance in multiple crop species - Nature...
Nature· 4 days agoIn this study, Mo et al. describe a novel biotechnological strategy to produce crop plants resistant to lepidopteran pests.
How bioinformatics led one scientist home to Lithuania
Nature· 2 days agoJuozas Gordevičius founded a data-science company in the United States before returning to Vilnius.
Will Editas Medicine (EDIT) Report Negative Q1 Earnings? What You Should Know
Zacks via Yahoo Finance· 7 days agoEditas (EDIT) doesn't possess the right combination of the two key ingredients for a likely earnings...
Study introduces improved way to grow cells that give rise to kidney's filtration system
Medical Xpress· 3 days agoIn a study published in Cell Stem Cell, USC scientists report significant progress in cultivating nephron progenitor cells (NPCs), the cells destined to form the kidney's filtration system, ...
State of New Jersey Common Pension Fund D Has $2.48 Million Position in Intellia Therapeutics, Inc....
ETF DAILY NEWS· 18 hours agoState of New Jersey Common Pension Fund D raised its position in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 26.6% during the 4th quarter, according to its most recent filing ...
Allspring Global Investments Holdings LLC Acquires Shares of 39,059 Caribou Biosciences, Inc....
ETF DAILY NEWS· 5 days agoAllspring Global Investments Holdings LLC purchased a new stake in Caribou Biosciences, Inc. (NASDAQ:CRBU – Free Report) in the 4th quarter, according to its most recent Form 13F filing with ...